Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹18 Cr.
Stock P/E
72.8
P/B
1.8
Current Price
₹28.5
Book Value
₹ 15.8
Face Value
10
52W High
₹57
52W Low
₹ 28.5
Dividend Yield
0%

Pentokey Organy (I) Overview

Business

Pentokey Organy (India) Ltd. is primarily engaged in the business of trading. The company acts as a trader and distributor of various chemicals, including organic and inorganic chemicals, solvents, paints, and allied products. Its core business model involves procuring chemicals from manufacturers or larger distributors and supplying them to various industrial clients, earning a margin on the difference between purchase and sale prices. The company's operations are largely focused on the Indian domestic market.

Revenue Mix

The company's primary business activity is chemical trading. Detailed segmentation by specific chemical types, end-user industries, or geographical breakdown beyond India is not readily available in public disclosures. Revenue is largely derived from the sale of various chemical products.

Industry

The company operates within the broader Trading sector, specifically in the chemical trading industry in India. This industry is generally fragmented and competitive, with numerous players ranging from small local distributors to large integrated chemical companies. Pentokey Organy appears to be a relatively smaller player in this segment, competing primarily on price, relationships, and timely supply. Its positioning is likely that of a niche or regional supplier rather than a dominant market leader.

MOAT

Pentokey Organy operates in a highly commoditized and competitive trading sector, making durable competitive advantages challenging to establish. Potential limited advantages may include established relationships with specific suppliers and customers, efficient working capital management, or localized distribution network efficiencies. However, the company does not appear to possess strong moats such as significant brand recognition, proprietary technology, strong network effects, or substantial cost leadership typically associated with larger, more diversified chemical manufacturers or distributors.

Growth Drivers

Growth in End-User Industries: Increased demand from key chemical-consuming sectors in India such as pharmaceuticals, agrochemicals, paints & coatings, textiles, and manufacturing.

Product Portfolio Expansion: Diversification into new types of chemicals or related products that cater to existing or new customer bases.

Enhanced Supply Chain & Logistics: Improvements in sourcing, inventory management, and distribution efficiency could lead to better margins and market reach.

Strategic Alliances: Forging stronger relationships or exclusive distribution agreements with manufacturers for specific products.

Risks

Commodity Price Volatility: Fluctuations in the prices of chemicals and raw materials can directly impact trading margins.

Intense Competition: The fragmented nature of the chemical trading market leads to margin pressure from numerous competitors.

Supply Chain Disruptions: Dependency on timely and cost-effective procurement from suppliers makes the company vulnerable to disruptions in global or domestic supply chains.

Credit Risk: Exposure to credit risk from customers, especially in the trading business where payment terms can vary.

Regulatory Changes: Changes in import/export policies, environmental regulations, or chemical safety standards can affect operations and costs.

Working Capital Management: Effective management of inventory and receivables is crucial for profitability and liquidity in a trading business.

Management & Ownership

Pentokey Organy (India) Ltd. is a promoter-driven company. As of recent disclosures, the promoter group holds a significant stake, indicating a closely held and managed business. Specific details on the individual promoters' backgrounds or the full management team's experience would require deeper scrutiny of annual reports and corporate filings. Like many smaller Indian companies, strategic direction and operational control are likely concentrated within the promoter family.

Outlook

Pentokey Organy operates in a fundamental, yet competitive, segment of the Indian economy. The bull case for the company hinges on its ability to capitalize on the sustained growth of India's industrial and manufacturing sectors, which are major consumers of chemicals. Efficient inventory management, strong supplier relationships, and disciplined working capital practices could enable stable, albeit modest, profitability. The bear case revolves around the inherent challenges of the trading business: thin margins, intense competition, sensitivity to chemical price fluctuations, and potential supply chain vulnerabilities. The company's relatively small scale means it has less leverage against larger players and may face difficulties in absorbing significant market shocks or regulatory changes. Its performance will largely be dictated by its operational efficiency and ability to navigate market cycles effectively.

Pentokey Organy (I) Share Price

Live · BSE · Inception: 1986
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Pentokey Organy (I) Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 0 0 0 0 1 5 1 -2 -2 0
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 0 1 5 1 -2 -2 0
Total Expenditure 0 0 0 0 1 5 1 -2 -2 -0
Operating Profit 0 0 0 0 0 0 0 -0 -0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 0 0 0 -0 -0 0
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax 0 0 0 0 0 0 0 -0 -0 0
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 0 0 0 0 0 -0 -0 0
Adjusted Earnings Per Share 0.1 0.1 0.2 0.1 0.1 0.8 0.2 -0.5 -0.2 0.3

Pentokey Organy (I) Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 122 85 1 5 9 2 0 0 4 4 1 -3
Other Income 0 0 4 0 0 0 0 0 2 0 0 0
Total Income 122 86 5 5 9 2 0 0 7 5 1 -3
Total Expenditure 122 89 6 5 10 2 1 0 4 4 1 -3
Operating Profit -0 -3 -2 -0 -1 -0 -0 -0 3 1 0 0
Interest 3 4 2 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 14 1 1 0 0 0 0 0 0 0
Profit Before Tax -4 -7 10 0 0 -0 -0 -0 3 1 0 0
Provision for Tax 0 2 1 0 -0 0 0 0 0 0 0 0
Profit After Tax -4 -9 10 0 0 -0 -0 -0 3 1 0 0
Adjustments 0 0 0 0 0 -0 0 0 0 0 -0 0
Profit After Adjustments -4 -9 10 0 0 -0 -0 -0 3 1 0 0
Adjusted Earnings Per Share -7 -14.2 15.3 0 0.5 -0.7 -0.4 -0.3 5.1 1.4 0.4 -0.2

Pentokey Organy (I) Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 5 -4 6 6 6 6 5 5 8 9 9
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 12 12 7 0 0 0 0 0 0 0 0
Other Non-Current Liabilities -1 0 0 0 0 0 0 0 0 0 0
Total Current Liabilities 33 13 4 0 1 0 0 0 1 0 0
Total Liabilities 49 21 16 6 7 6 6 5 9 10 10
Fixed Assets 9 10 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 3 1 1 1 0 1 1 0 0 1 2
Total Current Assets 37 10 15 6 7 6 5 5 8 9 8
Total Assets 49 21 16 6 7 6 6 5 9 10 10

Pentokey Organy (I) Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 1 0 0 1 0 0 0 0 0 0
Cash Flow from Operating Activities 0 12 -3 8 -2 1 1 -0 -0 1 0
Cash Flow from Investing Activities 0 -0 16 -1 2 -1 -1 0 0 -1 -0
Cash Flow from Financing Activities -1 -12 -13 -7 -0 0 0 0 -0 -0 -0
Net Cash Inflow / Outflow -0 -0 -0 0 -0 -0 0 -0 0 -0 0
Closing Cash & Cash Equivalent 1 0 0 1 0 0 0 0 0 0 0

Pentokey Organy (I) Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -7.01 -14.25 15.32 0.02 0.5 -0.7 -0.38 -0.26 5.06 1.39 0.39
CEPS(Rs) -6.07 -13.25 16.33 0.12 0.5 -0.7 -0.38 -0.25 5.07 1.4 0.39
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 8.01 -6.23 9.09 9.12 9.63 8.91 8.54 8.29 13.36 14.77 15.08
Core EBITDA Margin(%) -0.57 -3.53 -682.36 -12.91 -8.72 -43.94 0 0 19.51 9.8 -25.97
EBIT Margin(%) -0.71 -3.94 1594.2 6.66 3.8 -28.21 0 0 73.39 20 30.19
Pre Tax Margin(%) -3.36 -7.99 1310.61 1.04 3.32 -28.23 0 0 72.74 19.85 29.71
PAT Margin (%) -3.36 -9.79 1242.11 0.24 3.36 -28.23 0 0 72.74 19.85 29.71
Cash Profit Margin (%) -2.91 -9.1 1323.67 1.57 3.39 -28.13 0 0 72.83 19.91 29.75
ROA(%) -8.95 -25.62 52.06 0.1 4.76 -6.78 -4.15 -3.04 44.81 9.47 2.55
ROE(%) -60.56 -1602.18 1074.63 0.2 5.3 -7.58 -4.39 -3.1 46.76 9.89 2.62
ROCE(%) -2.81 -15.51 93.86 3.5 6.01 -7.57 -4.38 -3.09 47.18 9.97 2.66
Receivable days 26.39 18.1 0 15.26 47.14 369.43 0 0 12.17 84.51 482.34
Inventory Days 38.02 29.41 128.71 7.53 7.04 0 0 0 17.2 0 144.64
Payable days 50.37 46.93 1622.07 35.95 18.99 124.43 0 0 24.62 23.3 44.32
PER(x) 0 0 0.82 878.03 26.36 0 0 0 8.19 40.26 80.86
Price/Book(x) 1.24 -2.97 1.37 1.74 1.36 0.75 1.27 2.18 3.11 3.79 2.1
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.26 0.34 18.58 1.66 0.59 0.26 2425.35 0 4.93 6.74 18.11
EV/Core EBITDA(x) -91.48 -9.55 -9.25 -18.39 -8.92 -0.92 -9.4 -43.91 6.71 33.61 59.92
Net Sales Growth(%) -1.53 -29.79 -99.11 517.42 97.51 -83.2 -99.94 -100 0 0.71 -81.21
EBIT Growth(%) -166.35 -284.69 442.92 -97.46 12.74 -224.61 45.49 31.94 2062.03 -72.56 -71.63
PAT Growth(%) -107.06 -103.21 207.53 -99.88 2652.91 -241.32 45.38 32.05 2042.2 -72.52 -71.86
EPS Growth(%) -107.06 -103.21 207.53 -99.88 2652.64 -241.34 45.38 32.04 2041.89 -72.52 -71.86
Debt/Equity(x) 5.43 -4.6 1.14 0 0 0 0 0 0 0 0
Current Ratio(x) 1.1 0.74 4.06 12.35 7.84 11.72 38.45 92.03 15.6 36.93 24.5
Quick Ratio(x) 0.67 0.7 5.56 12.17 7.51 11.72 38.45 92.03 15.22 36.93 23.5
Interest Cover(x) -0.27 -0.97 5.62 1.18 7.85 -1319.47 -363.06 -816.5 112.42 131.22 63.95
Total Debt/Mcap(x) 4.38 1.55 0.83 0 0 0 0 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -75% — -13% -38%
Operating Profit CAGR -100% — — —
PAT CAGR -100% — — —
Share Price CAGR -38% -20% +6% +6%
ROE Average +3% +20% +10% -49%
ROCE Average +3% +20% +10% +12%

Pentokey Organy (I) Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 73.03 %
FII 0 %
DII (MF + Insurance) 2.31 %
Public (retail) 24.66 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 73.0373.0373.0373.0373.0373.0373.0373.0373.0373.03
FII 0000000000
DII 2.312.312.312.312.312.312.312.312.312.31
Public 24.6624.6624.6624.6624.6624.6624.6624.6624.6624.66
Others 0000000000
Total 100100100100100100100100100100

Pentokey Organy (I) Peer Comparison

Pentokey Organy (I) Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Pentokey Organy (I) Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Debtor days have increased from 23.3 to 44.32days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp